Mohammed S Taghour

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Vascular Endothelial Growth Factor

Molecular Docking

Papillary Thyroid

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Future medicinal chemistry

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Souad A El-Metwally, Hazem Elkady, Muhammad A Hagras, Eslam B Elkaeed, Bshra Ali A Alsfouk, Ahmed S Doghish, Ibrahim M Ibrahim, Mohammed S Taghour, Dalal Z Husein, Ahmed M Metwaly, Ibrahim H Eissa
Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3- d ]pyrimidine. Future medicinal chemistry (2023)
Mohammed S Taghour, Hazem Elkady, Wagdy M Eldehna, Nehal El-Deeb, Ahmed M Kenawy, Abeer E Abd El-Wahab, Eslam B Elkaeed, Bshra A Alsfouk, Ahmed M Metwaly, Ibrahim H Eissa
Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies. Journal of biomolecular structure & dynamics (2023)
Hazem A Mahdy, Hazem Elkady, Mohammed S Taghour, Elwan Alaa, Mohammed A Dahab, Mohamed A Elkady, Elsayed Ge Elsakka, Eslam B Elkaeed, Bshra Ali A Alsfouk, Ibrahim M Ibrahim, Ibrahim H Eissa, Ahmed M Metwaly
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations. Future medicinal chemistry (2023)
Mohammed S Taghour, Hazem Elkady, Wagdy M Eldehna, Nehal El-Deeb, Ahmed M Kenawy, Eslam B Elkaeed, Bshra A Alsfouk, Mohamed S Alesawy, Dalal Z Husein, Ahmed M Metwaly, Ibrahim H Eissa
Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway. PloS one 17 (9) (2022)
Elwan Alaa, Abdallah E Abdallah, Hazem A Mahdy, Mohammed A Dahab, Mohammed S Taghour, Eslam B Elkaeed, Ahmed B M Mehany, Ahmed Nabeeh, Mohammed Adel, Aisha A Alsfouk, Hazem Elkady, Ibrahim H Eissa
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation. Molecules (Basel, Switzerland) 27 (15) (2022)
Nawaf A Alsaif, Hazem A Mahdy, A F M Motiur Rahman, Ahmad J Obaidullah, Hamad M Alkahtani, Abdullah M Al-Hossaini, Abdulrahman A Al-Mehizi, Alaa Elwan, Mohammed S Taghour
Targeting VEGFR-2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies. Archiv der Pharmazie (2021)
Nawaf A Alsaif, Mohammed S Taghour, A F M Motiur Rahman, Ahmad J Obaidullah, Abdulrahman A Al-Mehizia, Manal M Alanazi, Saleh Aldawas, Elwan Alaa, Hazem Elkady
Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
A F M Motiur Rahman, Elwan Alaa, Nawaf A Alsaif, Ahmad J Obaidullah, Hamad M Al Kahtani, Abdulrahman A Al-Mehizia, Sultan M Alsubaie, Mohammed S Taghour, Ibrahim H Eissa
Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Mohamed S Alesawy, Abdallah E Abdallah, Mohammed S Taghour, Eslam B Elkaeed, Ibrahim H Eissa, Ahmed M Metwaly
In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro). Molecules (Basel, Switzerland) 26 (9) (2021)